Taiwan-based United Biomedical Inc. (UBI) Asia has had its request for emergency use authorization (EUA) for its COVID-19 vaccine denied after its vaccine candidate did not meet Taiwan's antibody standard in its Phase 2 clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Flights, trains, ferry services in Taiwan affected by Typhoon Usagi
11/14/2024 11:52 PM - Sports
Taiwan edges Dominican Republic in second straight Premier12 group win
11/14/2024 11:39 PM - Society
Employee falls to her death at karaoke club in Taipei
11/14/2024 11:10 PM - Cross-Strait
MAC criticizes retired naval officer for 'praising' China military
11/14/2024 10:52 PM - Society